{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T11:46:10Z","timestamp":1792237570035,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chinese Science Council personal fellowship"},{"name":"ZonMw Vici award to FF"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chromosomal instability (CIN) is a defining feature of triple-negative breast cancer (TNBC) and is increasingly recognized as a driver of tumor evolution and immune escape. However, how CIN\n                    <jats:sup>HIGH<\/jats:sup>\n                    tumor cells modulate innate immune cells, particularly macrophages, remains unclear. Here, we used the MPS1 inhibitor reversine to induce acute CIN in the TNBC cell line MDA-MB-231 and examined its impact on human macrophage polarization and function. Reversine-induced CIN stably increased the expression of macrophage-attracting cytokines, including CCL2, CCL5, and IL-6. In direct co-cultures, reversine-treated cancer cells promoted M2-like macrophage polarization, accompanied by a modest increase of M1-like markers, whereas in non-contact transwell co-cultures, soluble paracrine signals from reversine-treated TNBC cells only promoted M2-like polarization. Furthermore, macrophages exposed to reversine-treated TNBC cells showed enhanced uptake of cancer cells, further underscoring their activation by cells with reversine-induced CIN. Finally, we found that macrophage activation coincided with the secretion of factors that promoted cancer cell migration, suggesting that immune-cancer cell interaction promotes metastasis. Together, our findings show that drug-induced CIN in TNBC cells promotes polarization of co-cultured macrophages, promoting an immunosuppressive, pro-migratory niche that may be exploitable for therapies targeting CIN-associated immune modulation.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-55242-0","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:52:47Z","timestamp":1780699967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Induced chromosomal instability in triple negative breast cancer cells promotes M2-like polarization of macrophages"],"prefix":"10.1038","volume":"16","author":[{"given":"Ruifang","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris","family":"Foijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"key":"55242_CR1","doi-asserted-by":"crossref","unstructured":"Zagami, P. & Carey, L. A. Triple negative breast cancer: Pitfalls and progress. NPJ Breast Cancer 8, (2022).","DOI":"10.1038\/s41523-022-00468-0"},{"key":"55242_CR2","doi-asserted-by":"crossref","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nature Biotechnology 2012 30:5 30, 413\u2013421 (2012).","DOI":"10.1038\/nbt.2203"},{"key":"55242_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tig.2007.11.006","volume":"24","author":"JB Geigl","year":"2008","unstructured":"Geigl, J. B., Obenauf, A. C., Schwarzbraun, T. & Speicher, M. R. Defining \u2018chromosomal instability\u2019. Trends Genet. 24, 64\u201369 (2008).","journal-title":"Trends Genet."},{"key":"55242_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41576-024-00761-7","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen, X., Agustinus, A. S., Li, J., DiBona, M. & Bakhoum, S. F. Chromosomal instability as a driver of cancer progression. Nat. Rev. Genet. 26, 31\u201346 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"55242_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0002-9440(10)64194-6","volume":"161","author":"DS Yoon","year":"2002","unstructured":"Yoon, D. S. et al. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am. J. Pathol. 161, 391 (2002).","journal-title":"Am. J. Pathol."},{"key":"55242_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467 (2018).","journal-title":"Nature"},{"key":"55242_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell 173, 581 (2018).","journal-title":"Cell"},{"key":"55242_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.devcel.2017.05.022","volume":"41","author":"S Santaguida","year":"2017","unstructured":"Santaguida, S. et al. Chromosome mis-segregation generates cell-cycle-arrested cells with complex karyotypes that are eliminated by the immune system. Dev. Cell. 41, 638-651.e5 (2017).","journal-title":"Dev. Cell."},{"key":"55242_CR9","doi-asserted-by":"crossref","unstructured":"Davoli, T., Uno, H., Wooten, E. C. & Elledge, S. J. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science 355, (2017).","DOI":"10.1126\/science.aaf8399"},{"key":"55242_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2019.1657374","author":"R Tripathi","year":"2019","unstructured":"Tripathi, R., Modur, V., Senovilla, L., Kroemer, G. & Komurov, K. Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion. Oncoimmunology https:\/\/doi.org\/10.1080\/2162402x.2019.1657374 (2019).","journal-title":"Oncoimmunology"},{"key":"55242_CR11","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","volume":"620","author":"J Li","year":"2023","unstructured":"Li, J. et al. Non-cell-autonomous cancer progression from chromosomal instability. Nature 620, 1080\u20131088 (2023).","journal-title":"Nature"},{"key":"55242_CR12","doi-asserted-by":"crossref","unstructured":"Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550, (2017).","DOI":"10.1038\/nature24050"},{"key":"55242_CR13","doi-asserted-by":"publisher","unstructured":"Schubert, M. et al. Cancer tolerance to chromosomal instability is driven by Stat1 inactivation in vivo. bioRxiv 2021.12.03.471107 (2021) https:\/\/doi.org\/10.1101\/2021.12.03.471107.","DOI":"10.1101\/2021.12.03.471107"},{"key":"55242_CR14","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812-830.e14 (2018).","journal-title":"Immunity"},{"key":"55242_CR15","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam, A. et al. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 233, 6425\u20136440 (2018).","journal-title":"J. Cell. Physiol."},{"key":"55242_CR16","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-020-1073-3","volume":"26","author":"D Cerezo-Wallis","year":"2020","unstructured":"Cerezo-Wallis, D. et al. Midkine rewires the melanoma microenvironment toward a tolerogenic and immune-resistant state. Nat. Med. 26, 1865\u20131877 (2020).","journal-title":"Nat. Med."},{"key":"55242_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: From mechanisms to therapy. Immunity 41, 49\u201361 (2014).","journal-title":"Immunity"},{"key":"55242_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2018.12.038","volume":"176","author":"M Georgouli","year":"2019","unstructured":"Georgouli, M. et al. Regional activation of Myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment. Cell 176, 757-774.e23 (2019).","journal-title":"Cell"},{"key":"55242_CR19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2407-13-421","volume":"13","author":"JY Jang","year":"2013","unstructured":"Jang, J. Y., Lee, J. K., Jeon, Y. K. & Kim, C. W. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. BMC Cancer 13, 421 (2013).","journal-title":"BMC Cancer"},{"key":"55242_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41416-024-02715-6","volume":"131","author":"JH Rannikko","year":"2024","unstructured":"Rannikko, J. H. & Hollm\u00e9n, M. Clinical landscape of macrophage-reprogramming cancer immunotherapies. Br. J. Cancer 131, 627\u2013640 (2024).","journal-title":"Br. J. Cancer"},{"key":"55242_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.immuni.2020.01.014","volume":"52","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP. Immunity 52, 357-373.e9 (2020).","journal-title":"Immunity"},{"key":"55242_CR22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s44319-024-00363-8","volume":"26","author":"S Zheng","year":"2025","unstructured":"Zheng, S. et al. High CDC20 levels increase sensitivity of cancer cells to MPS1 inhibitors. EMBO Rep. 26, 1036\u20131061 (2025).","journal-title":"EMBO Rep."},{"key":"55242_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","volume":"23","author":"W Chanput","year":"2014","unstructured":"Chanput, W., Mes, J. J. & Wichers, H. J. THP-1 cell line: An in vitro cell model for immune modulation approach. Int. Immunopharmacol. 23, 37\u201345 (2014).","journal-title":"Int. Immunopharmacol."},{"key":"55242_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008668","volume":"5","author":"M Daigneault","year":"2010","unstructured":"Daigneault, M., Preston, J. A., Marriott, H. M., Whyte, M. K. B. & Dockrell, D. H. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS ONE 5, e8668 (2010).","journal-title":"PLoS ONE"},{"key":"55242_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jim.2016.01.012","volume":"430","author":"ME Lund","year":"2016","unstructured":"Lund, M. E., To, J., O\u2019Brien, B. A. & Donnelly, S. The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus. J. Immunol. Methods 430, 64\u201370 (2016).","journal-title":"J. Immunol. Methods"},{"key":"55242_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cellimm.2018.07.008","volume":"332","author":"MA Forrester","year":"2018","unstructured":"Forrester, M. A. et al. Similarities and differences in surface receptor expression by THP-1 monocytes and differentiated macrophages polarized using seven different conditioning regimens. Cell. Immunol. 332, 58 (2018).","journal-title":"Cell. Immunol."},{"key":"55242_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12865-016-0170-z","volume":"17","author":"G Bener","year":"2016","unstructured":"Bener, G. et al. Silencing of CD47 and SIRP\u03b1 by Polypurine reverse Hoogsteen hairpins to promote MCF-7 breast cancer cells death by PMA-differentiated THP-1 cells. BMC Immunol. 17, 1\u201312 (2016).","journal-title":"BMC Immunol."},{"key":"55242_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206818","volume":"13","author":"MMM Enr\u00edquez","year":"2018","unstructured":"Enr\u00edquez, M. M. M., F\u00e9lix, A. J., Ciudad, C. J. & No\u00e9, V. Cancer immunotherapy using PolyPurine Reverse Hoogsteen hairpins targeting the PD-1\/PD-L1 pathway in human tumor cells. PLoS ONE 13, e0206818 (2018).","journal-title":"PLoS ONE"},{"key":"55242_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194821","volume":"13","author":"CC Stempin","year":"2021","unstructured":"Stempin, C. C. et al. Secreted factors by anaplastic thyroid cancer cells induce tumor-promoting M2-like macrophage polarization through a TIM3-dependent mechanism. Cancers (Basel) 13, 4821 (2021).","journal-title":"Cancers (Basel)"},{"key":"55242_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2147\/JHC.S300165","volume":"8","author":"Y Zhuang","year":"2021","unstructured":"Zhuang, Y., Zhao, X., Yuan, B., Zeng, Z. & Chen, Y. Blocking the CCL5\u2013CCR5 axis using Maraviroc promotes M1 polarization of macrophages cocultured with irradiated hepatoma cells. J. Hepatocell. Carcinoma 8, 599 (2021).","journal-title":"J. Hepatocell. Carcinoma"},{"key":"55242_CR31","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.1638","volume":"5","author":"MP Smith","year":"2015","unstructured":"Smith, M. P., Young, H., Hurlstone, A. & Wellbrock, C. Differentiation of THP1 cells into macrophages for Transwell co-culture assay with melanoma cells. Bio-Protoc. 5, e1638 (2015).","journal-title":"Bio-Protoc."},{"key":"55242_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108468","volume":"104","author":"Z Wu","year":"2022","unstructured":"Wu, Z. et al. 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages. Int. Immunopharmacol. 104, 108468 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"55242_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677\u2013686 (2004).","journal-title":"Trends Immunol."},{"key":"55242_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-015-1546-9","volume":"15","author":"M Genin","year":"2015","unstructured":"Genin, M., Clement, F., Fattaccioli, A., Raes, M. & Michiels, C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer 15, 1\u201314 (2015).","journal-title":"BMC Cancer"},{"key":"55242_CR35","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.1073\/pnas.1305569110","volume":"110","author":"D Tseng","year":"2013","unstructured":"Tseng, D. et al. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc. Natl. Acad. Sci. U. S. A. 110, 11103\u201311108 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"55242_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mc.22539","volume":"56","author":"CV Rao","year":"2017","unstructured":"Rao, C. V., Asch, A. S. & Yamada, H. Y. Emerging links among Chromosome Instability (CIN), cancer, and aging. Mol. Carcinog. 56, 791\u2013803 (2017).","journal-title":"Mol. Carcinog."},{"key":"55242_CR37","doi-asserted-by":"crossref","unstructured":"Hayes, B. H. et al. Chromosomal instability can favor macrophage-mediated immune response and induce a broad, vaccination-like anti-tumor IgG response. Elife 12, (2023).","DOI":"10.7554\/eLife.88054.1"},{"key":"55242_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113266","author":"S Kandala","year":"2023","unstructured":"Kandala, S. et al. Chronic chromosome instability induced by Plk1 results in immune suppression in breast cancer. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2023.113266 (2023).","journal-title":"Cell Rep."},{"key":"55242_CR39","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","volume":"548","author":"SM Harding","year":"2017","unstructured":"Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548, 466\u2013470 (2017).","journal-title":"Nature"},{"key":"55242_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.immuni.2011.09.004","volume":"35","author":"KS Ravichandran","year":"2011","unstructured":"Ravichandran, K. S. Beginnings of a good apoptotic meal: The Find-Me and Eat-Me Signaling Pathways.. Immunity 35, 445\u2013455 (2011).","journal-title":"Immunity"},{"key":"55242_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni.3253","volume":"16","author":"S Arandjelovic","year":"2015","unstructured":"Arandjelovic, S. & Ravichandran, K. S. Phagocytosis of apoptotic cells in homeostasis.. Nat. Immunol. 16, 907\u2013917 (2015).","journal-title":"Nat. Immunol."},{"key":"55242_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115807","volume":"168","author":"YL Zhang","year":"2026","unstructured":"Zhang, Y. L., Zang, H. & Wen, Q. Macrophage polarization in tumors: The impact of efferocytosis.. Int. Immunopharmacol. 168, 115807 (2026).","journal-title":"Int. Immunopharmacol."},{"key":"55242_CR43","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.molcel.2014.03.040","volume":"54","author":"X Cai","year":"2014","unstructured":"Cai, X., Chiu, Y. H. & Chen, Z. J. The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Mol. Cell 54, 289\u2013296 (2014).","journal-title":"Mol. Cell"},{"key":"55242_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","volume":"14","author":"LB Ivashkiv","year":"2014","unstructured":"Ivashkiv, L. B. & Donlin, L. T. Regulation of type I interferon responses.. Nat. Rev. Immunol. 14, 36\u201349 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"55242_CR45","doi-asserted-by":"crossref","unstructured":"Lee, H.-S. et al. Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies. Cancer Res. 76, 902\u201311 (2016).","DOI":"10.1158\/0008-5472.CAN-15-1617"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55242-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55242-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55242-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:02:02Z","timestamp":1787054522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55242-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55242"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55242-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FF is CSO of iPsomics. He does not stand any financial benefit from this role and the work in this study is unrelated to this. The other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"25782"}}